BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17276738)

  • 21. TRB3 inhibits the transcriptional activation of stress-regulated genes by a negative feedback on the ATF4 pathway.
    Jousse C; Deval C; Maurin AC; Parry L; Chérasse Y; Chaveroux C; Lefloch R; Lenormand P; Bruhat A; Fafournoux P
    J Biol Chem; 2007 May; 282(21):15851-61. PubMed ID: 17369260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of a mitochondrial genetic defect on capacitative calcium entry and mitochondrial organization in the osteosarcoma cells.
    Szczepanowska J; Zabłocki K; Duszyński J
    FEBS Lett; 2004 Dec; 578(3):316-22. PubMed ID: 15589839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter demethylation of the asparagine synthetase gene is required for ATF4-dependent adaptation to asparagine depletion.
    Jiang J; Srivastava S; Seim G; Pavlova NN; King B; Zou L; Zhang C; Zhong M; Feng H; Kapur R; Wek RC; Fan J; Zhang J
    J Biol Chem; 2019 Dec; 294(49):18674-18684. PubMed ID: 31659118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pathogenic A3243G mutation in human mitochondrial tRNALeu(UUR) decreases the efficiency of aminoacylation.
    Park H; Davidson E; King MP
    Biochemistry; 2003 Feb; 42(4):958-64. PubMed ID: 12549915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolomic profiling rationalized pyruvate efficacy in cybrid cells harboring MELAS mitochondrial DNA mutations.
    Kami K; Fujita Y; Igarashi S; Koike S; Sugawara S; Ikeda S; Sato N; Ito M; Tanaka M; Tomita M; Soga T
    Mitochondrion; 2012 Nov; 12(6):644-53. PubMed ID: 22884939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different effects of novel mtDNA G3242A and G3244A base changes adjacent to a common A3243G mutation in patients with mitochondrial disorders.
    Mimaki M; Hatakeyama H; Ichiyama T; Isumi H; Furukawa S; Akasaka M; Kamei A; Komaki H; Nishino I; Nonaka I; Goto Y
    Mitochondrion; 2009 Apr; 9(2):115-22. PubMed ID: 19460299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alteration in the copy number of mitochondrial DNA in leukocytes of patients with mitochondrial encephalomyopathies.
    Liu CS; Cheng WL; Lee CF; Ma YS; Lin CY; Huang CC; Wei YH
    Acta Neurol Scand; 2006 May; 113(5):334-41. PubMed ID: 16629770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of NARP (neurogenic muscle weakness, ataxia, and retinitis pigmentosa) with a T-to-C point mutation at nt 8993 of mitochondrial DNA].
    Mitani M; Jinnai K; Takahashi K; Koide R; Tsuji S
    Rinsho Shinkeigaku; 2000 Jun; 40(6):600-4. PubMed ID: 11086401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) with the A3243G mutation of the tRNALeu(UUR) gene of mtDNA in native American haplogroup B2].
    Delgado-Sánchez R; Zárate-Moysen A; Monsalvo-Reyes A; Herrero MD; Ruiz-Pesini E; López-Pérez M; Montoya J; Montiel-Sosa JF
    Rev Neurol; 2007 Jan 1-15; 44(1):18-22. PubMed ID: 17199225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of mtDNA variant segregation during early human embryonic development: a tool for successful NARP preimplantation diagnosis.
    Steffann J; Frydman N; Gigarel N; Burlet P; Ray PF; Fanchin R; Feyereisen E; Kerbrat V; Tachdjian G; Bonnefont JP; Frydman R; Munnich A
    J Med Genet; 2006 Mar; 43(3):244-7. PubMed ID: 16155197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioenergetics of mitochondrial diseases associated with mtDNA mutations.
    Lenaz G; Baracca A; Carelli V; D'Aurelio M; Sgarbi G; Solaini G
    Biochim Biophys Acta; 2004 Jul; 1658(1-2):89-94. PubMed ID: 15282179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of complex I genes in MELAS: a novel heteroplasmic mutation 3380G>A in ND1 of mtDNA.
    Horváth R; Reilmann R; Holinski-Feder E; Ringelstein EB; Klopstock T
    Neuromuscul Disord; 2008 Jul; 18(7):553-6. PubMed ID: 18590963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage.
    Indo HP; Davidson M; Yen HC; Suenaga S; Tomita K; Nishii T; Higuchi M; Koga Y; Ozawa T; Majima HJ
    Mitochondrion; 2007; 7(1-2):106-18. PubMed ID: 17307400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondria in cybrids containing mtDNA from persons with mitochondriopathies.
    Swerdlow RH
    J Neurosci Res; 2007 Nov; 85(15):3416-28. PubMed ID: 17243174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PGD to reduce reproductive risk: the case of mitochondrial DNA disorders.
    Bredenoord AL; Dondorp W; Pennings G; De Die-Smulders CE; De Wert G
    Hum Reprod; 2008 Nov; 23(11):2392-401. PubMed ID: 18664474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial defects in neurodegenerative disease.
    Wallace DC
    Ment Retard Dev Disabil Res Rev; 2001; 7(3):158-66. PubMed ID: 11553931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial deafness.
    Kokotas H; Petersen MB; Willems PJ
    Clin Genet; 2007 May; 71(5):379-91. PubMed ID: 17489842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Variation in manifestations of heteroplasmic mtDNA mutation 8993 T>G in two families].
    Tesarová M; Hansíková H; Hlavatá A; Klement P; Houst'ková H; Houstĕk J; Zeman J
    Cas Lek Cesk; 2002 Aug; 141(17):551-4. PubMed ID: 12404959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NARP mutation and mtDNA depletion trigger mitochondrial biogenesis which can be modulated by selenite supplementation.
    Wojewoda M; Duszyński J; Szczepanowska J
    Int J Biochem Cell Biol; 2011 Aug; 43(8):1178-86. PubMed ID: 21550418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Peripheral neuropathies due to mitochondrial disorders].
    Funalot B
    Rev Neurol (Paris); 2009 Dec; 165(12):1118-21. PubMed ID: 19942242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.